eClinicalMedicine

Papers
(The H4-Index of eClinicalMedicine is 77. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact1590
Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies567
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge437
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis434
Cognitive deficits in people who have recovered from COVID-19386
Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis372
The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis340
Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review316
Prevalence and correlates of stress and burnout among U.S. healthcare workers during the COVID-19 pandemic: A national cross-sectional survey study297
The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study292
Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review258
Sleep problems during COVID-19 pandemic and its’ association to psychological distress: A systematic review and meta-analysis245
Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis217
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial206
Impaired spermatogenesis in COVID-19 patients201
The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis197
COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis187
Quantifying the global burden of mental disorders and their economic value183
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis181
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China180
Pharmacotherapy of obesity: an update on the available medications and drugs under investigation159
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis157
Social media and attitudes towards a COVID-19 vaccination: A systematic review of the literature154
Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis153
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.149
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy145
COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing144
Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine141
Diagnosis of COVID-19 by analysis of breath with gas chromatography-ion mobility spectrometry - a feasibility study141
Global, regional, and national dengue burden from 1990 to 2017: A systematic analysis based on the global burden of disease study 2017140
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial139
Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019139
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months137
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study136
The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study135
Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study134
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors132
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks131
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India129
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis124
Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study123
Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns122
Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection119
Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019115
Changes and correlates of screen time in adults and children during the COVID-19 pandemic: A systematic review and meta-analysis113
Suicide numbers during the first 9-15 months of the COVID-19 pandemic compared with pre-existing trends: An interrupted time series analysis in 33 countries111
Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England110
Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: A value of statistical life approach108
Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19108
Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial107
How to improve access to medical imaging in low- and middle-income countries ?106
Global changes in maternity care provision during the COVID-19 pandemic: A systematic review and meta-analysis105
Linguistic markers predict onset of Alzheimer's disease104
Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial100
Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases99
Second wave of COVID-19 pandemic in India: Barriers to effective governmental response95
Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–202295
Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study93
Advancing women in healthcare leadership: A systematic review and meta-synthesis of multi-sector evidence on organisational interventions93
Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants93
Fatigue and cognitive impairment after COVID-19: A prospective multicentre study93
Symptom Persistence Despite Improvement in Cardiopulmonary Health – Insights from longitudinal CMR, CPET and lung function testing post-COVID-1992
Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action91
Epidemiology and clinical features of COVID-19 outbreaks in aged care facilities: A systematic review and meta-analysis91
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 201991
Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review91
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial89
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation89
Global economic productivity losses from vision impairment and blindness87
Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study87
An evaluation of the mental health impact of SARS-CoV-2 on patients, general public and healthcare professionals: A systematic review and meta-analysis85
SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis84
High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis84
An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C81
A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States81
Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient 80
Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach79
Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey77
0.069233894348145